Press "Enter" to skip to content

New patent for Orexo Us drug ZUBSOLV

3
Copyright © DrugPatentWatch. Originally published at New patent for Orexo Us drug ZUBSOLV

Annual Drug Patent Expirations for ZUBSOLV
Annual Drug Patent Expirations for ZUBSOLV

Zubsolv is a drug marketed by Orexo Us Inc and is included in one NDA. There are five patents protecting this drug and four Paragraph IV challenges.

ZUBSOLV drug price trends.

Drug patent litigation for ZUBSOLV.

This drug has forty patent family members in twenty-eight countries.

The generic ingredient in ZUBSOLV is buprenorphine hydrochloride; naloxone hydrochloride. Additional details are available on the buprenorphine hydrochloride; naloxone hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Orexo Us drug ZUBSOLV
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions